EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States

Narut Prasitlumkum, Juan F Rodriguez-Riascos iD, Hema Vemulapalli iD, Aakash Somappa iD, Camilo A Estrada-Vargas iD, Olubadewa A Fatunde iD, Carlos A Rojas, Poojan Prajapati iD, Keerthika Vijayakumar iD, Suraj Kapa iD, Duy Nguyen, Samuel Asirvatham iD und 11 weitere

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70503 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Narut Prasitlumkum und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Ventricular Premature Complexes, Tachycardia, Ventricular, Catheter Ablation. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mayo Clinic Arizona Cardiovascular Clinical Research Center (MCA CV CRC), Mayo Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited.

Objective

To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry.

Methods

This retrospective study included consecutive patients undergoing PFA for ventricular tachycardia (VT) or premature ventricular contractions (PVCs) at three Mayo Clinic centers (April 2024 to July 2025). The primary feasibility outcome was the successful delivery of PFA lesions to the intended target substrate. Primary efficacy outcomes included acute procedural success; sustained VT recurrence requiring implantable cardioverter‐defibrillator (ICD) shocks or multiple antitachycardia pacing therapies; and ≥ 80% reduction in PVC burden. Safety outcomes included procedural complications, valvular function, thromboembolic events, renal function, and conduction disturbances.

Results

Twenty‐six patients were included (13 PVC, 13 VT). Acute success was achieved in all VT ablations (69.2% complete; 30.8% partial) and in 92.3% of PVC ablations. Complications occurred in 11.5% of patients (transient LBBB [ n = 1] and vascular complications [ n = 2]). No thromboembolic events, intracardiac thrombus, or acute kidney injury were observed. Lesions near the mitral valve apparatus did not worsen mitral regurgitation, including in patients with pre‐existing valve disease. After a median follow‐up of 365 days, one patient experienced VT recurrence requiring ICD shocks. Estimated recurrence‐free survival after VT ablation was 61.5% at 12 months; 58.3% of PVC patients achieved ≥ 80% burden reduction.

Conclusion

PFA for VA appears feasible and acutely effective, with a low rate of procedure‐related complications. While acute success was high, long‐term outcomes were acceptable for VT ablation and relatively modest for PVC ablation, highlighting the need for continued refinement of technology and energy‐delivery strategies. Larger prospective studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular Premature ComplexesTachycardia, VentricularCatheter AblationHumansFemaleRegistriesFeasibility StudiesMaleMiddle AgedRetrospective StudiesTime FactorsAgedRecurrenceRisk FactorsTreatment OutcomeUnited StatesIrreversible Electroporation TherapyHeart RateAction PotentialsRisk AssessmentAdult

Stichwörter der Autor:innen

electroporationpremature ventricular complexespulsed field ablationreal‐world registryventricular tachycardia

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.
  • Division Chair-Cardiothoracic Radiology, Mayo Clinic, Phoenix, Arizona, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA.

ORCID-Profile: Juan F Rodriguez-Riascos, Hema Vemulapalli, Aakash Somappa, Camilo A Estrada-Vargas, Olubadewa A Fatunde, Poojan Prajapati, Keerthika Vijayakumar, Suraj Kapa, Samuel Asirvatham, Christopher McLeod, Hicham Z El Masry, Abhishek J Deshmukh, Ammar M Killu, Siva K Mulpuru, Luis R Scott, Komandoor Srivathsan

Förderung

  • Mayo Clinic Arizona Cardiovascular Clinical Research Center (MCA CV CRC)
  • Mayo Clinic

Zitieren

APA

Prasitlumkum, N., Rodriguez-Riascos, J. F., Vemulapalli, H., Somappa, A., Estrada-Vargas, C. A., Fatunde, O. A., Rojas, C. A., Prajapati, P., Vijayakumar, K., Kapa, S., Nguyen, D., Asirvatham, S., Madhavan, M., McLeod, C., Masry, H. Z. E., Deshmukh, A. J., Kella, D. K., Killu, A. M., Mulpuru, S. K., …, & Srivathsan, K. (2026). Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70503

Vancouver

Prasitlumkum N, Rodriguez-Riascos JF, Vemulapalli H, Somappa A, Estrada-Vargas CA, Fatunde OA, et al. Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70503

BibTeX
@article{Prasitlumkum2026,
  author = {Prasitlumkum, Narut and Rodriguez-Riascos, Juan F and Vemulapalli, Hema and Somappa, Aakash and Estrada-Vargas, Camilo A and Fatunde, Olubadewa A and Rojas, Carlos A and Prajapati, Poojan and Vijayakumar, Keerthika and Kapa, Suraj and Nguyen, Duy and Asirvatham, Samuel and Madhavan, Malini and McLeod, Christopher and Masry, Hicham Z El and Deshmukh, Abhishek J and Kella, Danesh K and Killu, Ammar M and Mulpuru, Siva K and Sardana, Mayank and Scott, Luis R and Sugrue, Alan M and Srivathsan, Komandoor},
  title = {Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70503}
}
Kostenlos starten →